nach oben

Lasers in Medical Science

Erschienen in:

29.01.2022 | Original Article

The facilitating effect of blue light on the antifungal agent susceptibilities of passaged conidia from the ocular-derived Fusarium solani species complex

verfasst von: Yujie Cen, Yingyu Li, Pei Zhang, Ziyuan Liu, Chen Huang, Wei Wang

Erschienen in: Lasers in Medical Science | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

The eye is a light-receiving organ and has anatomical advantages to accept phototherapy. Fungi colonizing on the eyes, which cause ocular mycoses, are affected by daily blue light and could easily accept additional light irritation. Ocular mycoses are recalcitrant and blindness-causing eye diseases, and antifungal agent treatments are insufficient. Our team previously found that blue light could inhibit Fusarium solani hyphal growth but promote conidiation. Here, we investigated the antifungal susceptibilities and biological characteristics of the passaged conidia. Twelve Fusarium solani strains (11 ocular-derived strains and 1 standard laboratory strain) were inoculated under blue light (0.5 mW/cm²) and darkness conditions, respectively, to obtain the passaged conidia of blue light group (n = 12) and darkness group (n = 12). Two groups were tested to determine the growth abilities and in vitro antifungal susceptibilities to five antifungal drugs (voriconazole (VRC), amphotericin B (AMB), terbinafine (TRB), caspofungin (CAS), and 5-flucytosine (5FC)), which were examined by microscopy for morphological observation and spectrophotometry for turbidity analysis. The results showed that blue light group passaged conidia were more sensitive to antifungal drugs (AMB, VRC, TRB, and CAS) compared to darkness group. The MIC₅₀ of VRC significantly decreased after blue light treatment (P < 0.05). The fungal inhibition rate significantly increased for VRC, AMB, and TRB in the low concentration range (P < 0.05 or P < 0.01). Blue light did not affect germination or hyphal extension of passaged conidia. These results suggested that blue light could facilitate fungal inhibition effect of AMB, VRC, TRB, and CAS and may improve the therapeutic efficiency in VRC and AMB clinical applications. Blue light phototherapy may provide a new adjuvant approach for the treatment of ocular mycosis.

Nur mit Berechtigung zugänglich

Corrochano LM (2019) Light in the fungal world: from photoreception to gene transcription and beyond. Annu Rev Genet 53:149–170. https://doi.org/10.1146/annurev-genet-120417-031415CrossRefPubMed

Avalos J, Estrada AF (2010) Regulation by light in Fusarium. Fungal Genet Biol: FG & B 47(11):930–938. https://doi.org/10.1016/j.fgb.2010.05.001CrossRef

De Lucca AJ, Carter-Wientjes C, Williams KA, Bhatnagar D (2012) Blue light (470 nm) effectively inhibits bacterial and fungal growth. Lett Appl Microbiol 55(6):460–466. https://doi.org/10.1111/lam.12002CrossRefPubMed

Tang Y, Zhu P, Lu Z, Qu Y, Huang L, Zheng N, Wang Y, Nie H, Jiang Y, Xu L (2020) The photoreceptor components FaWC1 and FaWC2 of Fusarium asiaticum cooperatively regulate light responses but play independent roles in virulence expression. Microorganisms 8(3):365. https://doi.org/10.3390/microorganisms8030365CrossRefPubMedCentral

Trzaska WJ, Wrigley HE, Thwaite JE, May RC (2017) Species-specific antifungal activity of blue light. Sci Rep 7(1):4605. https://doi.org/10.1038/s41598-017-05000-0CrossRefPubMedPubMedCentral

Fanelli F, Schmidt-Heydt M, Haidukowski M, Susca A, Geisen R, Logrieco A, Mule G (2012) Influence of light on growth, conidiation and fumonisin production by Fusarium verticillioides. Fungal Biol 116(2):241–248. https://doi.org/10.1016/j.funbio.2011.11.007CrossRefPubMed

Slowik M, Biernat MM, Urbaniak-Kujda D, Kapelko-Slowik K, Misiuk-Hojlo M (2015) Mycotic infections of the eye. Adv Clin Exp Med Off Organ Wroclaw Med Univ 24(6):1113–1117. https://doi.org/10.17219/acem/50572CrossRef

Cen Y, Li Y, Huang C, Wang W (2020) Bibliometric and visualized analysis of global research on fungal keratitis from 1959 to 2019. Medicine 99(22):e20420. https://doi.org/10.1097/MD.0000000000020420CrossRefPubMed

Ansari Z, Miller D, Galor A (2013) Current thoughts in fungal keratitis: diagnosis and treatment. Curr Fungal Infect Rep 7(3):209–218. https://doi.org/10.1007/s12281-013-0150-110.1007/s12281-013-0150-1CrossRefPubMedPubMedCentral

10.

Sahay P, Singhal D, Nagpal R, Maharana PK, Farid M, Gelman R, Sinha R, Agarwal T, Titiyal JS, Sharma N (2019) Pharmacologic therapy of mycotic keratitis. Surv Ophthalmol 64(3):380–400. https://doi.org/10.1016/j.survophthal.2019.02.007CrossRefPubMed

11.

Li Y, Zhang P, Huang C, Wang W (2020) Dual effect of blue light on Fusariumsolani clinical corneal isolates in vitro. Lasers Med Sci 35(6):1299–1305. https://doi.org/10.1007/s10103-019-02911-4CrossRefPubMed

12.

Li C, Jia X, Bian Y, Qi D, Wu J (2020) Different susceptibility of spores and hyphae of Trichophyton rubrum to methylene blue mediated photodynamic treatment in vitro. Mycoses. https://doi.org/10.1111/myc.13182CrossRefPubMedPubMedCentral

13.

Al-Hatmi AM, Meis JF, de Hoog GS (2016) Fusarium: molecular diversity and intrinsic drug resistance. PLoS Pathog 12(4):e1005464. https://doi.org/10.1371/journal.ppat.1005464CrossRefPubMedPubMedCentral

14.

Xie L, Zhong W, Shi W, Sun S (2006) Spectrum of fungal keratitis in north China. Ophthalmology 113(11):1943–1948. https://doi.org/10.1016/j.ophtha.2006.05.035CrossRefPubMed

15.

Tupaki-Sreepurna A, Al-Hatmi AM, Kindo AJ, Sundaram M, de Hoog GS (2017) Multidrug-resistant Fusarium in keratitis: a clinico-mycological study of keratitis infections in Chennai, India. Mycoses 60(4):230–233. https://doi.org/10.1111/myc.12578CrossRefPubMed

16.

Thomas PA, Kaliamurthy J (2013) Mycotic keratitis: epidemiology, diagnosis and management. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 19(3):210–220. https://doi.org/10.1111/1469-0691.12126CrossRef

17.

Walther G, Stasch S, Kaerger K, Hamprecht A, Roth M, Cornely OA, Geerling G, Mackenzie CR, Kurzai O, von Lilienfeld-Toal M (2017) Fusarium keratitis in Germany. J Clin Microbiol 55(10):2983–2995. https://doi.org/10.1128/JCM.00649-17CrossRefPubMedPubMedCentral

18.

Oechsler RA, Feilmeier MR, Miller D, Shi W, Hofling-Lima AL, Alfonso EC (2013) Fusarium keratitis: genotyping, in vitro susceptibility and clinical outcomes. Cornea 32(5):667–673. https://doi.org/10.1097/ICO.0b013e318277ac74CrossRefPubMedPubMedCentral

19.

Espinel-Ingroff A, Colombo AL, Cordoba S, Dufresne PJ, Fuller J, Ghannoum M, Gonzalez GM, Guarro J, Kidd SE, Meis JF, Melhem TM, Pelaez T, Pfaller MA, Szeszs MW, Takahaschi JP, Tortorano AM, Wiederhold NP, Turnidge J (2016) International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrob Agents Chemother 60(2):1079–1084. https://doi.org/10.1128/AAC.02456-15CrossRefPubMedPubMedCentral

20.

Clinical and Laboratory Standards Institute (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard-2nd ed. CLSI document M38-A2. CLSI, Wayne

21.

Meletiadis J, Meis JF, Mouton JW, Verweij PE (2001) Analysis of growth characteristics of filamentous fungi in different nutrient media. J Clin Microbiol 39(2):478–484. https://doi.org/10.1128/JCM.39.2.478-484.2001CrossRefPubMedPubMedCentral

22.

Meletiadis J, te Dorsthorst DT, Verweij PE (2003) Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi. J Clin Microbiol 41(10):4718–4725. https://doi.org/10.1128/jcm.41.10.4718-4725.2003CrossRefPubMedPubMedCentral

23.

Odds FC, Motyl M, Andrade R, Bille J, Canton E, Cuenca-Estrella M, Davidson A, Durussel C, Ellis D, Foraker E, Fothergill AW, Ghannoum MA, Giacobbe RA, Gobernado M, Handke R, Laverdiere M, Lee-Yang W, Merz WG, Ostrosky-Zeichner L, Peman J, Perea S, Perfect JR, Pfaller MA, Proia L, Rex JH, Rinaldi MG, Rodriguez-Tudela JL, Schell WA, Shields C, Sutton DA, Verweij PE, Warnock DW (2004) Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J Clin Microbiol 42(8):3475–3482. https://doi.org/10.1128/JCM.42.8.3475-3482.2004CrossRefPubMedPubMedCentral

24.

Te Dorsthorst DT, Zwaaftink RB, Rijs AJ, Meletiadis J, Verweij PE (2007) A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin. Med Mycol 45(4):351–355. https://doi.org/10.1080/13693780701216485CrossRef

25.

Liang QF, Jin XY, Wang XL, Sun XG (2009) Effect of topical application of terbinafine on fungal keratitis. Chin Med J 122(16):1884–1888PubMed

26.

Dupont D, Saison J, Miailhes P, Mouchel R, Wallon M, Persat F (2020) Aspergillus endophthalmitis: potential role for vitreous galactomannan testing? Int J Infect Dis IJID Off Publ Int Soc Infect Dis 96:151–153. https://doi.org/10.1016/j.ijid.2020.04.037CrossRef

27.

Neoh CF, Daniell M, Chen SC, Stewart K, Kong DC (2014) Clinical utility of caspofungin eye drops in fungal keratitis. Int J Antimicrob Agents 44(2):96–104. https://doi.org/10.1016/j.ijantimicag.2014.04.008CrossRefPubMed

28.

Mikami R, Stemmermann GN (1958) Keratomycosis caused by Fusarium oxysporum. Am J Clin Pathol 29(3):257–262. https://doi.org/10.1093/ajcp/29.3.257CrossRefPubMed

29.

Alfonso EC, Cantu-Dibildox J, Munir WM, Miller D, O’Brien TP, Karp CL, Yoo SH, Forster RK, Culbertson WW, Donaldson K, Rodila J, Lee Y (2006) Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol 124(7):941–947. https://doi.org/10.1001/archopht.124.7.ecs60039CrossRefPubMed

30.

Rees CA, Bao R, Zegans ME, Cramer RA (2019) Natamycin and voriconazole exhibit synergistic interactions with nonantifungal ophthalmic agents against Fusarium species ocular isolates. Antimicrob Agents Chemother 63(7):e02505-18. https://doi.org/10.1128/AAC.02505-18CrossRefPubMedPubMedCentral

31.

D’Agostino M, Lemmet T, Dufay C, Luc A, Frippiat JP, Machouart M, Debourgogne A (2018) Overinduction of CYP51A gene after exposure to azole antifungals provides a first clue to resistance mechanism in Fusarium solani species complex. Microb Drug Resist 24(6):768–773. https://doi.org/10.1089/mdr.2017.0311CrossRefPubMed

32.

Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, Johnson E, Meletiadis J, Pana ZD, Lackner M, Verweij P, Freiberger T, Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Guinea J, Guarro J, de Hoog S, Hope W, Kathuria S, Lortholary O, Meis JF, Ullmann AJ, Petrikkos G, Lass-Florl C, European Society of Clinical M, Infectious Diseases Fungal Infection Study G, European Confederation of Medical M (2014) ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clini Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20(Suppl 3):27–46

33.

Kim H, Son H, Lee YW (2014) Effects of light on secondary metabolism and fungal development of Fusarium graminearum. J Appl Microbiol 116(2):380–389. https://doi.org/10.1111/jam.12381CrossRefPubMed

34.

Niwano Y, Iwasawa A, Tsubota K, Ayaki M, Negishi K (2019) Protective effects of blue light-blocking shades on phototoxicity in human ocular surface cells. BMJ Open Ophthalmol 4(1):e000217. https://doi.org/10.1136/bmjophth-2018-000217CrossRefPubMedPubMedCentral

35.

Huang C, Zhang P, Wang W, Xu Y, Wang M, Chen X, Dong X (2014) Long-term blue light exposure induces RGC-5 cell death in vitro: involvement of mitochondria-dependent apoptosis, oxidative stress, and MAPK signaling pathways. Apoptosis Int J Programmed Cell Death 19(6):922–932. https://doi.org/10.1007/s10495-014-0983-2CrossRef

36.

Tosini G, Ferguson I, Tsubota K (2016) Effects of blue light on the circadian system and eye physiology. Mol Vis 22:61–72PubMedPubMedCentral

37.

Marek V, Melik-Parsadaniantz S, Villette T, Montoya F, Baudouin C, Brignole-Baudouin F, Denoyer A (2018) Blue light phototoxicity toward human corneal and conjunctival epithelial cells in basal and hyperosmolar conditions. Free Radical Biol Med 126:27–40. https://doi.org/10.1016/j.freeradbiomed.2018.07.012CrossRef

38.

Arnault E, Barrau C, Nanteau C, Gondouin P, Bigot K, Vienot F, Gutman E, Fontaine V, Villette T, Cohen-Tannoudji D, Sahel JA, Picaud S (2013) Phototoxic action spectrum on a retinal pigment epithelium model of age-related macular degeneration exposed to sunlight normalized conditions. PLoS ONE 8(8):e71398. https://doi.org/10.1371/journal.pone.0071398CrossRefPubMedPubMedCentral

39.

Nunez-Alvarez C, Osborne NN (2019) Enhancement of corneal epithelium cell survival, proliferation and migration by red light: relevance to corneal wound healing. Exp Eye Res 180:231–241. https://doi.org/10.1016/j.exer.2019.01.003CrossRefPubMed

40.

Vemulakonda GA, Hariprasad SM, Mieler WF, Prince RA, Shah GK, Van Gelder RN (2008) Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans. Arch Ophthalmol 126(1):18–22. https://doi.org/10.1001/archophthalmol.2007.8CrossRefPubMed

41.

Shen YC, Wang MY, Wang CY, Tsai TC, Tsai HY, Lee YF, Wei LC (2007) Clearance of intravitreal voriconazole. Invest Ophthalmol Vis Sci 48(5):2238–2241. https://doi.org/10.1167/iovs.06-1362CrossRefPubMed

42.

Qu L, Li L, Xie H (2010) Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model. Ophthalmic Res 43(3):153–158. https://doi.org/10.1159/000254566CrossRefPubMed

43.

Goldblum D, Rohrer K, Frueh BE, Theurillat R, Thormann W, Zimmerli S (2002) Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model. Antimicrob Agents Chemother 46(12):3719–3723. https://doi.org/10.1128/aac.46.12.3719-3723.2002CrossRefPubMedPubMedCentral

44.

Shen YC, Liang CY, Wang CY, Lin KH, Hsu MY, Yuen HL, Wei LC (2014) Pharmacokinetics and safety of intravitreal caspofungin. Antimicrob Agents Chemother 58(12):7234–7239. https://doi.org/10.1128/AAC.03324-14CrossRefPubMedPubMedCentral

45.

Moorhead S, Maclean M, MacGregor SJ, Anderson JG (2016) Comparative sensitivity of Trichophyton and aspergillus conidia to inactivation by violet-blue light exposure. Photomed Laser Surg 34(1):36–41. https://doi.org/10.1089/pho.2015.3922CrossRefPubMed

46.

Jeffet U, Shimon R, Sterer N (2020) Effect of high intensity blue light on fusobacterium nucleatum membrane integrity. Photochem Photobiol 96(1):178–181. https://doi.org/10.1111/php.13151CrossRefPubMed

47.

Bocking T, Barrow KD, Netting AG, Chilcott TC, Coster HG, Hofer M (2000) Effects of singlet oxygen on membrane sterols in the yeast Saccharomyces cerevisiae. Eur J Biochem 267(6):1607–1618. https://doi.org/10.1046/j.1432-1327.2000.01179.xCrossRefPubMed

Titel: The facilitating effect of blue light on the antifungal agent susceptibilities of passaged conidia from the ocular-derived Fusarium solani species complex
verfasst von: Yujie Cen
Yingyu Li
Pei Zhang
Ziyuan Liu
Chen Huang
Wei Wang
Publikationsdatum: 29.01.2022
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 3/2022
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-021-03415-w

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

The effectiveness and safety of low-level laser therapy on breast cancer–related lymphedema: An overview and update of systematic reviews

Laser interstitial thermal therapy for newly diagnosed glioblastoma

Correction to: Efficiency and safety of laser‑assisted hatching on vitrified‑warmed blastocyst transfer cycles: a prospective control trial

Beneficial effects of infrared light-emitting diode in corticosteroid-resistant asthma

Comparison between cryotherapy and photobiomodulation in muscle recovery: a systematic review and meta-analysis

Effect of transcranial near-infrared photobiomodulation on cognitive outcomes in D-galactose/AlCl3 induced brain aging in BALB/c mice